Amedica's ceramic spinal implant:
This article was originally published in Clinica
Executive Summary
Orthopaedics firm Amedica has been granted a special 510(k) marketing clearance by the US FDA for its Valeo ceramic vertebral body replacement (VBR) spinal implant. The device is intended to aid in surgical stabilisation of the thoracolumbar spine. The Valeo VBR incorporates the Salt Lake City, Utah company's novel silicon nitride ceramic, which provides functionalities that are not available in devices currently on the market. The implant should restore the biomechanical integrity of the anterior, middle and posterior spine, even in the absence of fusion, for a prolonged period of time, said the company.
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.